Pharmaceutical rebate agreements with accession option

BARMER Beschaffung und Vergabe·Wuppertal, Germany·Deadline Nov 01, 2027 · 430 days left·Open·Supplies·Framework

Registrieren zum Speichern

Structured notice only

Originaltitel der Bekanntmachung

Germany – Pharmaceutical products – Arzneimittelrabattverträge mit Beitrittsoption

20/100

Opportunity Score

Needs reviewMedium complexity

SuppliesFrameworkOpen

Warum diese Bewertung?

Chance

20 / 100

Komplexität

45 / 100

Risikofaktoren

No estimated value, award criteria, or eligibility criteria are provided. This makes it impossible to assess the tender...

The notice states it is not a public procurement under EU Directive 2014/24/EU, yet it uses the open procedure label. T...

No procurement documents available

Tiefe Portfolioanalyse

Tiefe Analyse der Unternehmenspassung

Verwendet:

Description
Industries & Services
Capabilities
Market & Experience
Certifications

Überblick

Moderate opportunity

Wichtige Fakten

Framework procurement
Supplies contract
2 lots
Duration until Dec 2027
Supply of pharmaceutical products containing Aflibercept 40 mg/ml in two forms: vials (Durchstechflaschen) and pre-filled syringes (Fertigspritzen).
Framework agreement with accession option (Beitrittsoption) allowing additional parties to join.

Vollständige Zusammenfassung anzeigen

This is a German framework agreement with accession option for pharmaceutical products (Aflibercept) issued by BARMER Beschaffung und Vergabe. It consists of two lots: one for vials (40 mg/ml) and one for pre-filled syringes (40 mg/ml). The notice explicitly states it is not a public procurement under EU directives, but uses an open procedure format. No estimated values, award criteria, or eligibility criteria are provided. The submission deadline is November 1, 2027, with a two-year contract period starting December 1, 2025. The buyer is a health insurance body. The tender is available only electronically via the buyer's platform. Documents were not analyzed beyond the XML notice.

Risiken

No estimated value, award criteria, or eligibility criteria are provided. This makes it impossible to assess the tender...

The notice states it is not a public procurement under EU Directive 2014/24/EU, yet it uses the open procedure label. T...

No procurement documents available

Analyse kann unvollständig sein

Nur ein Teil der Vergabeunterlagen wurde analysiert. Weitere Anforderungen, Zertifikate oder Einreichungsdokumente können in den übrigen Unterlagen enthalten sein.

Wichtige Anforderungen

Technical

Maximum of 2 lots can be awarded to one tenderer (MaximumLotsAwardedNumeric: 2).
Variants are not allowed.

Administrative

Tenders must be submitted electronically via the buyer's platform (Portal öffnen).

Anforderungen können unvollständig sein.

Auftraggeber

Name

BARMER Beschaffung und Vergabe

Ort

Wuppertal, DEU

E-Mail

[email protected]

Website

www.barmer.de

Kennung

992-80322-57

Tätigkeit

Health

Lose (2)

LOT-0001

Aflibercept (Vials 40 mg/ml)

Supply of medicinal products containing Aflibercept in vial form (40 mg/ml). Framework agreement with accession option.

SuppliesFrameworkEU fundedElectronic submission

Ort

Wuppertal, Germany

Dauer

Nov 2025 - Dec 2027

Kategorie

Pharmaceutical products

Frist

Deadline Nov 01, 2027

LOT-0002

Aflibercept (Pre-filled Syringes 40 mg/ml)

Supply of medicinal products containing Aflibercept in pre-filled syringe form (40 mg/ml). Framework agreement with accession option.